CEO of Optic, a leading provider of AI-powered drug discovery infrastructure. He is leading the charge in helping pharmaceutical companies accelerate their R&D with AI-driven small-molecule drug discovery.
Prior to founding Optic, Andrey held key leadership roles at Google, where he was the founding product leader at YouTube's Mobile Applications team and Google's VR/AR/Stadia teams.
Under Andrey's leadership, Optic has assembled a world-class team of AI experts and life science professionals. Together, they are building a powerful platform that empowers researchers to accelerate drug discovery and identify promising new therapeutics.
Optic is backed by VCs of Amazon, Google, Twitter and crypto native Pantera Capital.
Contributing Author
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
